Skip to main content
OpenTrials
Completed

NCT Number: NCT04565418

Exercise to Restore 24h Rhythms in Metabolism

This study will investigate the effect of exercise training on 24h rhythms in substrate metabolism in overweight subjects with impaired glucose tolerance. Subjects will perform exercise training for 12 weeks. Before and after the exercise period, they will be admitted to research facilities for 45 hours to assess 24h rhythms in substrate metabolism. In a single-arm longitudinal design, subjects will serve as their own control.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–75 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Maastricht University

Maastricht, Netherlands

About this study

Recent evidence shows that pre-diabetes is characterized by marked alterations in 24h substrate metabolism, indicating metabolic inflexibility with an inability to fully switch to fat oxidation during the night. Whereas exercise has been shown to promote mitochondrial function and insulin sensitivity, it is unknown to if exercise training is able to restore 24h rhythmicity in overall substrate metabolism and muscle metabolism in human subjects with pre-diabetes.

In this single-arm longitudinal design, subjects will serve as their own control. Subjects will perform high-intensity interval training for 12 weeks (3x times per week) on a cycle ergometer at the research facility. Pre and post exercise, subjects will stay in a metabolic chamber and adhere to a relatively normal life-style in order to standardize the main 24h measurement period. As the primary outcome, substrate metabolism will be measured with a ventilated hood system and by indirect calorimetry in the chambers. Muscle biopsies from the vastus lateralis and frequent blood samples will also be taken over the course of the 24h. Thereby, ex-vivo skeletal muscle mitochondrial function and muscle clock gene expression will serve as the main secondary outcomes.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Caucasian
  • Healthy (as determined by dependent physician)
  • Overweight: BMI 25 - 35 kg/m2
  • Prediabetic based on one or a combination of the following criteria:
  • Impaired Glucose Tolerance (IGT): plasma glucose values ≥ 7.8 mmol/l and ≤ 11.1 mmol/l 120 minutes after glucose drink consumption during OGTT in screening.
  • Impaired Fasting Glucose (IFG): Fasting plasma glucose ≥ 6.1 mmol/l and ≤ 6.9 mmol/l.
  • Insulin Resistance: glucose clearance rate ≤ 360ml/kg/min, as determined using the OGIS120 model.
  • HbA1c of 5.7-6.4%.
  • Regular sleeping time (normally 7 - 9h daily)
  • Stable dietary habits: no weight gain or loss > 3kg in the last three months.

Exclusion criteria

  • Use of anticoagulants
  • Previously diagnosed with type 2 diabetes
  • Current alcohol consumption > 20 grams alcohol/day
  • Extreme early bird or extreme night person (score ≤ 30 or ≥ 70 on MEQ-SA questionnaire)
  • Heavily varying sleep-wake rhythm
  • Nightshift work during last 3 months
  • Travel across > 1 time zone in the last 3 months
  • Significant food allergies/intolerance (seriously hampering study meals)
  • Using > 400mg caffeine daily (more than 4 coffee or energy drink)
  • Smoking

Treatment and study plan

High-intensity interval training

Behavioral

3 times per week high-intensity interval training (HIIT) will be performed on a cycle ergometer for 12 weeks adding up to 36 HIIT sessions

Primary outcomes

  1. Change in 24 rhythm in whole-body energy metabolism (energy expenditure)

    Time frame: measured at 8:00, 13:00, 18:00, 23:00, 04:00 of the main test day before and after 12 weeks of exerise

    Energy expenditure (kJ/min) measured by indirect calorimetry

  2. Change in 24 rhythm in whole-body energy metabolism (glucose oxidation)

    Time frame: measured at 8:00, 13:00, 18:00, 23:00, 04:00 of the main test day before and after 12 weeks of exercise

    Energy expenditure (kJ/min) measured by indirect calorimetry

  3. Change in 24 rhythm in whole-body energy metabolism (fat oxidation)

    Time frame: measured at 8:00, 13:00, 18:00, 23:00, 04:00 of the main test day before and after 12 weeks of exercise

    Energy expenditure (kJ/min) measured by indirect calorimetry

Secondary outcomes

  1. Change in 24 rhythm in skeletal muscle mitochondrial respiration

    Time frame: measured at 8:00, 13:00, 23:00 of the main test day before and after 12 weeks of exercise

    O2-flux (pmol/mg/s) measured with high resolution respirometry

  2. Change in 24h rhythm in muscle protein levels of markers involved in molecular clock and mitochondrial metabolism

    Time frame: measured at 8:00, 13:00, 23:00 of the main test day before and after 12 weeks of exercise

    Quantify protein levels by Western blots

  3. Change in 24h rhythm in muscle DNA of markers involved in molecular clock and mitochondrial metabolism

    Time frame: measured at 8:00, 13:00, 23:00 of the main test day before and after 12 weeks of exercise

    Quantify DNA by qPCR

  4. Change in 24h rhythm in muscle DNA involved in molecular clock and mitochondrial metabolism.

    Time frame: measured at 8:00, 13:00, 23:00 of the main test day before and after 12 weeks of exercise

    Quantify DNA by micro-array

  5. Change in 24h rhythm in muscle mRNA markers involved in molecular clock and mitochondrial metabolism

    Time frame: measured at 8:00, 13:00, 23:00 of the main test day before and after 12 weeks of exercise

    Quantify mRNA levels by micro array

  6. Change in 24 rhythm of markers of normal 24h rhythm (cortisol)

    Time frame: every two hours for 24 hours beginning at 08:00 of the main test day before and after 12 weeks of exercise

    Blood cortisol levels

  7. Change in 24 rhythm of markers of normal 24h rhythm (melatonin)

    Time frame: every two hours for 24 hours beginning at 08:00 of the main test day before and after 12 weeks of exercise

    Blood melatonin levels

  8. Change in 24 rhythm of markers of normal 24h rhythm (core body temperature)

    Time frame: measured continuously for 24 hours on the main test day before and after 12 weeks of exercise

    Core body temperature measured by an ingested telemetric pill

  9. Change in 24h rhythm in serum glucose

    Time frame: every two hours for 24 hours beginning at 08:00 of the main test day before and after 12 weeks of exercise

    Serum glucose levels determined from venous blood draws

  10. Change in 24h rhythm in serum insulin

    Time frame: every two hours for 24 hours beginning at 08:00 of the main test day before and after 12 weeks of exercise

    Serum insulin levels determined from venous blood draws

  11. Change in 24h rhythm in serum free fatty acids (FFA)

    Time frame: every two hours for 24 hours beginning at 08:00 of the main test day before and after 12 weeks of exercise

    Serum FFA levels determined from venous blood draws

  12. Change in 24h rhythm in serum triglycerides

    Time frame: every two hours for 24 hours beginning at 08:00 of the main test day before and after 12 weeks of exercise

    Serum triglycerides levels determined from venous blood draws

  13. Change in 24h rhythm in serum cholesterol

    Time frame: every two hours for 24 hours beginning at 08:00 of the main test day before and after 12 weeks of exercise

    Serum cholesterol levels determined from venous blood draws

Sponsors and collaborators

Lead sponsor

Maastricht University

Other

Registry information

Official study title

Exercise to Restore 24h Rhythmicity in Substrate Metabolism of Prediabetes Subjects

Acronym: RESTORE

Important dates

Study start
2021
Primary completion
2022
Study completion
2023
First posted
Sep 25, 2020
Registry last updated
May 24, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.